CD8A and T-cell leukemia: The first transgenic mouse model expressing STAT5BN642H in the hematopoietic system (vav promoter) developed an aggressive CD8+ T cell leukemia with organ infiltrations by CD8+, CD4+, and γδ T cells [84,137].